期刊文献+

GSTM1基因多态性和膀胱癌遗传易感性关系

Genetic polymorphisms of GSTM1 and susceptibility to bladder cancer
下载PDF
导出
摘要 目的:探讨谷胱甘肽转移酶(GSTM1)基因多态性与膀胱癌遗传易感性的关系。方法:采用面访填写调查表,以PCR技术、病例对照研究方法,对252例病理证实原发膀胱移行细胞癌患者和320例健康对照者的GSTM1基因型进行检测。结果:膀胱癌患者GSTM1缺失基因型频率为45.2%,对照组为30.9%,两组比较差别有显著性意义(P<0.05),OR值为1.89(95%CI=1.28~4.40)。吸烟者中,患者组GSTM1缺失基因型频率为66.2%,对照组为27.3%,差别显著(P<0.01),OR值为8.9(95%CI=5.36~14.82)。同时憋尿及有家族肿瘤史也能增加患膀胱癌的危险性,但多饮牛奶则能降低膀胱癌的危险性,而水果摄入多少与膀胱癌发生危险性无统计学意义。结论:GSTM1基因多态性与膀胱癌易感性有关,该基因多态性与吸烟在膀胱癌的发生发展中起协同作用。 Objective:To study the association between genetic polymorphisms of glutathione-S-transferases mu (GSTM)1 and susceptibility to bladder cancer. Methods.. We obtained information on demographic factors,medical history,lifetime of tobacoo smoking and alcohol drinking, and occupational exposures by a personal interview. In a case control study,252 patients with primary bladder transitional carcinoma proved by pathological examination and 320 age- and sex-matched controls were included. The GSTM1 genotype was determined by PCR. Results:The frequency of GSTM1 null genotype was 45.2% in the bladder cancer patients and 30.9% in controls (OR= 1.89,95%CI= 1.28-4.40). The difference was significant (P〈0.05). In smokers, the frequency of GSTM1 null genotype was 66.2% in the bladder cancer patients and 27.3% in controls (OR=8.9,95%CI= 5.36-14.82). The difference was significant (P〈0.01). The risk of bladder cancer increased in subjects with the habit of compulsive urinary retention and the family history of cancer. Milk intake decreased the risk of bladder cancer. There was no statistical significance between the intake of fruit and the risk of bladder cancer. Conelusion:GSTM1 polymorphisms are associated with susceptibility to bladder cancer. It has the synergistic effects with smoking in the development of bladder cancer. Bladder neoplasms;
出处 《肿瘤》 CAS CSCD 北大核心 2006年第4期352-354,共3页 Tumor
基金 国家重点基础研究发展规划(国家"973"项目编号:2002CB512908) 江苏省135重点医学人才基金(编号:0151)
关键词 膀胱肿瘤 谷胱甘肽转移酶类 多态现象(遗传学) 流行病学 分子 Glutathione transferase Polymorphism(genetics) Epidemiology,molecular
  • 相关文献

参考文献6

  • 1NG DP,TAN KW,ZHAO B,etal.CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women:influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation[J].Cancer Causes Control,2005,16(4):399-405.
  • 2RAMSAY H M,HARDEN P N,REECE S,et al.Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients:a preliminary analysis[J].J Invest Dermatol,2001,117 (2):251-255.
  • 3LEE SJ,CHO SH,PARK SK,et al.Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk[J].Cancer Lett,2002,177(2):173-179.
  • 4SRIVASTAVA DS,KUMAR A,MITTAL B,et al.Polymorphism of GSTM1 and GSTT1 genes in bladder cancer:a study from North India[J].Arch Toxicol,2004,78(8):430-434.
  • 5KIM EJ,JEONG P,QUAN C,et al.Genotypes of TNF-alpha,VEGF,hOGG1,GSTM1,and GSTT1:useful determinants for clinical outcome of bladder cancer[J].Urology,2005,65 (1):70-75.
  • 6邵剑锋,钱立新.膀胱癌代谢酶基因多态性研究进展[J].国外医学(肿瘤学分册),2005,32(8):627-629. 被引量:1

二级参考文献14

  • 1Srivastava DS, Kumar A, Mittal B, et al. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer:a study from North India. Arch Toxicol ,2004,78 ( 8 ) :430-434.
  • 2Giannakopoulos X, Charalabopoulos K, Baltogiannis D, et al. The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer. Anticancer Res ,2002,22 ( 6 ) :3801 -3804.
  • 3Sign SV, Xu BH, Tkalcevic GT, et al. Glutathione-linked detoxification pathway in normal and malignant human bladder tissue. Cancer Lett, 1994,77 ( 1 ) :15-24.
  • 4Salagovic J, Kalina I , Habalova V, et al. The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer. Physiol Res, 1999,48 ( 6 ) :465-471.
  • 5Brockmoller J, Cascorbi I, Kerb R, et al. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione Stransferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res, 1996,56 (17) :3915-3925.
  • 6Brockmoller J,Kerb R,Drakoulis N,et al. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case- control study. Cancer Res, 1994,54 ( 15 ) :4103-4111.
  • 7Lee S J, Cho SH, Park SK, et al. Combined effect of glutathione Stransferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett,2002,177 (2) :173-179.
  • 8Hung RJ,Boffetta P,Brennan P,et al. GST,NAT,SULT1A1 ,CYP1B1 genetic polymorphisms,interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer,2004,110(4) :598-604.
  • 9Kim WJ,Kim H,Kim CH,et al. GSTT1-null genotype is a protective factor against bladder cancer. Urology,2002,60(5 ) :913-918.
  • 10Kim WJ, Lee HL, Lee SC, et al. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol,2000,164( 1 ) :209-213.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部